Medisca recalls swapped drugs

Share this article:

FDA testing revealed that lots of Medisca's L-citrulline did not contain the drug, but did test positive for medication used to treat vertigo.

The regulator announced the testing results Monday, three days after notifying healthcare professionals of adverse events associated with some of Medisca's medication. L-citrulline is used to treat rare genetic disorders usually found in children.

Medisca has recalled eight lots of the drug.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.